BDBM652829 US20240059694, Compound I-13

SMILES CN(C)c1ccc(cc1)C(=O)Nc1ccc(c2OCOc12)-c1nn([C@@H]2CCCN(C2)C(=O)C=C)c2ncnc(N)c12

InChI Key InChIKey=XLTSMXXGRIGBEL-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 652829   

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 25nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 2nMAssay Description:Inhibition of BTK (unknown origin) preincubated for 10 mins followed by kinase substrate and ATP addition and measured for 20 mins by mobility shift ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Xi'An Xintong Pharmaceutical Research

US Patent
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 14nMAssay Description:Inhibition of JAK3 (unknown origin) preincubated for 10 mins followed by kinase substrate and ATP addition and measured for 30 mins by mobility shift...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 1.48E+4nMAssay Description:Inhibition of human ERG by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetTyrosine-protein kinase JAK1(Human)
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JAK1 (unknown origin) using kinetic substrate in presence of ATP by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetTyrosine-protein kinase JAK2(Human)
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JAK2 (unknown origin) using kinetic substrate in presence of ATP by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Human)
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM652829(US20240059694, Compound I-13)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of TYK2 (unknown origin) using kinetic substrate in presence of ATP by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed